NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) is pleased to announce the Company has signed a Definitive Master Licensing Agreement (the Agreement) with Delta 9 Cannabis Inc. (TSXV: NINE) (OTC: VRNDF) (Delta 9) in a deal that opens the Canadian market to NanoSphere’s patented groundbreaking delivery technology.

If you were hoping for a rager, you were on the wrong private jet. A tropical storm had delayed the flight from Ottawa to Newfoundland by eight hours, and the mood on board Canopy Growth CEO Bruce Linton’s chartered Embraer Legacy 450 on the evening of October 16 was celebratory but cautious. At midnight that night, Canada would become the first G20 nation (and the second country in the world, after Uruguay) to legalize marijuana for adult recreational use. Linton, who had arguably more of the stuff to sell than anyone on the planet, was racing to get to his company’s flagship Tweed store in St. John’s, in the Newfoundland time zone, where clocks are somewhat inconceivably set a half hour ahead of the next easternmost time zone. If the plane’s all-too-apt ETA of 10:17 p.m.

Ontario looking to ship same-day pot ahead of bricks-and-mortar rollout

Cannabis stocks in the US and Canada were having a positive session on Thursday, trading in the opposite direction of the S&P 500 Index.

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, climbed 1.5% to 263.78.

Buds:

The Green Organic Dutchman Holdings Ltd (TSE:TGOD) (OTCMKTS:TGODF) surged 10% to US$2.52 on the OTC Markets after announcing that the Ontario Superior Court of Justice has approved its spinoff of TGOD Acquisition Corp.

The proposed spinoff focuses on investments in the cannabis industry in Canada and internationally. The Green Organic Dutchman plans to distribute to its shareholders unit purchase warrants of TGOD Acquisition.

Recreational marijuana has been in legal in Canada since October 2018, but municipalities across the country are still unclear about their authority over consumption of the drug. There are a lot of legal grey areas and uncertainties as to how much control individual municipalities have.

Markham was one of the first cities in the Greater Toronto Area to opt out of having cannabis retail stores and also restricted consumption of the drug to private property. The city is now looking into how far it can go to restrict marijuana consumption.

Canada's persistent shortage of legal cannabis could drag on for years. The impending legalization of edible pot will only divert more product away from empty store shelves across the country. One industry insider said he now expects that shortage to endure until 2022.

"If it was just the current product set, I'd say a year to 18 months," said Chuck Rifici, CEO of the Toronto-based cannabis company Auxly.

"But because we have edibles and a bunch of new product types coming in October, I think it'll be the better part of three years before we have true equilibrium and oversupply in the space."

With the legalization of cannabis in this rapidly- growing industry, the cannabis market provides countless opportunities.

The Canadian marijuana stocks we’ve weeded out today are holdings companies that focus their investments on cannabis, taking advantage of the potential benefits the industry has to offer.

Leading investment crowdfunding platform OurCrowd is jumping into the hot cannabis sector. OurCrowd has launched a $30 million cannabis tech fund called 7thirty Opportunity Fund.

OurCrowd said it will build the “world’s leading global cannabis technology venture capital fund.” The new fund is said to be focused on cannabis technology companies in Medtech, Agtech, retail, e-commerce, marketplaces, SaaS solutions, and the deep-tech research in Cannabis. Headquartered in Boulder, Colorado – a state that has legalized recreational use of marijuana, the fund will be active globally and include activities in Israel, Canada, and the United States.

The global cannabis market is still in the early innings of a multi-year boom.

Thanks in large part to growing acceptance of cannabis - including Canada's legalization in October 2018, further U.S. state approval, and growing interest from corporate America the global market is expected to reach $146.4 billion by 2025, according to Grand View Research Inc. from $7.06 billion in 2016.

In addition, the growing adoption of cannabis in medical applications such as cancer, mental disorders, and chronic pain is expected to propel revenue growth even more. As millions of people living all over the world look to embrace its medicinal properties, marijuana companies are quickly gaining the attention of cannabis investors.

Canadians bought $54-million (US$41 million) of marijuana from stores in the first full month after sales were legalized, some of the clearest evidence yet of the market’s potential.

Statistics Canada’s figure for November released Wednesday follows an earlier estimate that sales were $43 million in the first two weeks following legalization on Oct. 17. The Ottawa-based agency added cannabis to standard monthly reports on retail sales as part of wider effort to update the nation’s economic accounts.

“Retail figures will vary as new stores continue to come on line and the marketplace continues to evolve,” the agency’s report said.